Methylentetrahydrofolate reductase and nitric oxide synthase polymorphism in patients with atherosclerosis and diabetes

Pathol Oncol Res. 2009 Dec;15(4):631-7. doi: 10.1007/s12253-009-9163-z. Epub 2009 Mar 29.

Abstract

The development of the atherosclerosis is based on multifactorial causes. In addition to the traditional risk factors, gene polymorphisms can play a role in the disease. Therefore in this study we investigated whether the eNOS and MTHFR gene polymorphisms is associated with myocardial infarction and stroke in patients with or without diabetes. We have identified polymorphisms in the NOS 3 gene and one of these polymorphisms, Glu(298-->)Asp, was found to be a major risk factor for carotid artery disease and myocardial infarction. Our results indicate that the MTHFR G677T allele is significantly associated with MI. MTHFR 677 G/T genotyping may be of clinical importance as a prognostic and therapeutic marker, although further studies are needed to substantiate this hypothesis.

MeSH terms

  • Alleles
  • Atherosclerosis / genetics*
  • Case-Control Studies
  • Diabetes Mellitus / genetics*
  • Female
  • Genetic Predisposition to Disease / genetics
  • Genotype
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Nitric Oxide Synthase Type III / genetics*
  • Polymorphism, Genetic / genetics*

Substances

  • Nitric Oxide Synthase Type III
  • Methylenetetrahydrofolate Reductase (NADPH2)